Clinical significance of an anti-Dib assessed by flow cytometry

Immunohematology

Volumn 13, Issue 3, 1997, Pages 93-96

  Leger, R ^a   Arndt, P ^a   Co, A ^a   O'Brien, L ^b   Garratty, G ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b Santa Monica UCLA Medical Center   (United States)

Author keywords

Anti Dib; Flow cytometry; Red cell survival; Transfusion reaction

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIBODY;

AGED; ARTICLE; BLOOD GROUP SYSTEM; CASE REPORT; CELL SURVIVAL; ERYTHROCYTE; FLOW CYTOMETRY; GASTRECTOMY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0030875797     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. b-first and second examples. Vox Sang 1967;13;314-8.
2. b found in a Japanese woman. Vox Sang 1971;20:271-3.
3. b. Vox Sang 1971;21:79-80.
4. b causing hemolytic disease of the newborn. Vox Sang 1976;31:61-3.
5. b. Am J Clin Pathol 1979;71:713-4.
6. Postoway N, Nance S, O'Neill P, Garratty G. Comparison of a practical differential agglutination procedure to flow cytometry in following the survival of transfused red cells (abstract). Transfusion 1985;25:453.
7. Valinsky JE, Marsh WL, Bianco C. Flow cytometric procedure for estimation of transfused erythrocyte survival "in vivo" (abstract).Transfusion 1985;25:478.
8. Read EJ, Crabill HE, Davey RJ. Flow cytometric determination of transfused red blood cell (RBC) survival in a patient with autoimmune hemolytic anemia (AIHA) (abstract). Transfusion 1985;25:451.
9. a in a patient who received Jk(a+) red cells (abstract). Transfusion 1985;25:482.
10. 51Cr, flow cytometric, IgG subclass, and monocyte erythrophagocytosis assays (abstract). Transfusion 1986;26:545.
11. b (abstract). Transfusion 1987;27:534.
12. Issitt PD, Valinsky JE, Marsh WL, DiNapoli J, Gutgsell NS. In vivo red cell destruction by anti-Lu6. Transfusion 1990;30:258-60.
13. Garratty G, Arndt P, Co A, Rodberg K, Furmanski M. Fatal hemolytic transfusion reaction resulting from ABO mistyping of a patient with acquired B antigen detectable only by some monoclonal anti-B reagents. Transfusion 1996;36:351-7.
14. Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda, MD: American Association of Blood Banks, 1996.
15. Petz LD, Garratty G. Acquired immune hemolytic anemias. New York: Churchill Livingstone, 1980.
16. Nance SJ, Garratty G. Application of flow cytometry to immunohematology. J Immunol Methods 1987;101:127-31.
17. Garratty G, Arndt P. Applications of flow cytofluorometry to transfusion science. Transfusion 1995;35:157-78.
18. Mollison PL, Engelfreit CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications, 1993:792-3;348.
19. Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions: a technical workshop. Arlington, VA: American Association of Blood Banks, 1982;91-119.
20. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-52.
21. Postoway N, Garratty G. Standardization of IgG subclass antiserums for use with sensitized red cells. Transfusion 1983;23:398-400.
22. Nance SJ, Arndt PA, Garratty G. The effect of fresh normal serum on monocyte monolayer assay reactivity (letter). Transfusion 1988;28:398-9.
23. b. Transfusion 1988;28:265-7.
24. Judd WJ, Oberman HA, Silenieks A, Steiner EA. Clinical significance of anti-Lan (letter). Transfusion 1984;24:181.
25. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Trans Med Rev 1990;IV:297-312.
26. Thompson JC, Shulman IA, Nelson JM, Okamoto M, Strautz R. Life-saving incompatible blood transfusion. Lab Med 1987;18:385-7.